Can I read Pharmaceuticals. Changes in Quality of Life, Adherence, and Kinesiophobia in Patients With Hemophilia Treated With EHL on EtoBox?

Pharmaceuticals. Changes in Quality of Life, Adherence, and Kinesiophobia in Patients With Hemophilia Treated With EHL by ruben is a document available to read on EtoBox.

What is Pharmaceuticals. Changes in Quality of Life, Adherence, and Kinesiophobia in Patients With Hemophilia Treated With EHL about?

The LongHest Project evaluated the efficacy of extended half-life (EHL) recombinant FVIII treatment in improving quality of life, treatment adherence, and kinesiophobia in patients with hemophilia over a 12-month period. Results showed significant improvements in perceived quality of life, adherence to treatment, and reduced kinesiophobia among the 46 participants. The study concluded that EHL prophylaxis can enhance the overall well-being of adult patients with hemophilia by requiring fewer infusions and r

Author

ruben

Language

EN